IBRX vs BIIB: Which Stock is Better?
Side-by-side comparison of Immunitybio Inc and Biogen Inc in 2026
IBRX
Immunitybio Inc
$8.20
BIIB
Biogen Inc
$183.34
Key Metrics Comparison
| Metric | IBRX | BIIB | Winner |
|---|---|---|---|
| Market Cap | $7.95B | $26.91B | BIIB |
| P/E Ratio | N/A | 20.88 | BIIB |
| EPS (TTM) | $N/A | $8.78 | BIIB |
| Revenue Growth | 4.1% | -0.1% | IBRX |
| Gross Margin | 99.3% | 78.9% | IBRX |
Analyze IBRX
Full quant analysis
Analyze BIIB
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is IBRX or BIIB a better investment?
Comparing IBRX and BIIB: Immunitybio Inc has a market cap of $7.95B while Biogen Inc has $26.91B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between IBRX and BIIB?
IBRX (Immunitybio Inc) and BIIB (Biogen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: IBRX or BIIB?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: IBRX or BIIB?
IBRX has higher revenue growth at 4.1% vs -0.1% for BIIB.
Which company is more profitable: IBRX or BIIB?
Immunitybio Inc (IBRX) has higher gross margins at 99.3% compared to 78.9% for BIIB.
Which is the larger company: IBRX or BIIB?
Biogen Inc (BIIB) is larger with a market cap of $26.91B compared to $7.95B for IBRX.
Should I buy IBRX or BIIB in 2026?
Both IBRX and BIIB have investment merit. IBRX trades at $8.20 while BIIB trades at $183.34. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between IBRX and BIIB stock?
Key differences: Market Cap ($7.95B vs $26.91B), P/E Ratio (N/A vs 20.9x), Revenue Growth (4.1% vs -0.1%), Gross Margin (99.3% vs 78.9%).